BackShandong Buchang Pharmaceuticals , Ltd. Overview

Shandong Buchang Pharmaceuticals , Ltd. Goodwill

Track Shandong Buchang Pharmaceuticals , Ltd.'s goodwill ($400M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$400.74M
↓ 35.37% YoYΔ $-219.30M vs prior year quarter

Peer trimmed avg / median

Loading

Shandong Buchang Pharmaceuticals , Ltd. Goodwill History

Loading

Shandong Buchang Pharmaceuticals , Ltd. vs. peers: Goodwill Comparison

Loading

Shandong Buchang Pharmaceuticals , Ltd. Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Shandong Buchang Pharmaceuticals , Ltd. (603858.SS) FAQ

As of the most recent data (June 2026), 603858.SS shows a goodwill of $400M. That compares with $620M in the prior-year period — down 35.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 603858.SS's goodwill is now $400M (was $620M) — a 35.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Shandong Buchang Pharmaceuticals , Ltd. is outperforming or lagging.

Tracking 603858.SS's goodwill over time shows whether Shandong Buchang Pharmaceuticals , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $400M That compares with $620M in the prior-year period — down 35.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Shandong Buchang Pharmaceuticals , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $400M) with ownership activity and broader fundamentals.